Study to Determine the Safety, Tolerability, and Efficacy of Evenamide in Patients With Chronic Schizophrenia
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
- Ravi Anand, MD
Newron Pharmaceuticals
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
14 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Help Hospitals Clinical Research Department
Vijayawada, Andhra Pradesh, India
- St. John'S Medical College Hospital
Koramangala, Karnataka, India
- Mangala Hospital and Mangala Kidney Foundation, Department of Psychiatry
Mangalore, Karnataka, India
- Iqraa Psychiatry Care and Rehabilitation Centre
Kozhikode, Kerala, India
- Deenanath Mangeshkar Hospital Research Center
Pune, Maharashtra, India
- Sujata Birla Hospital
Pune, Maharashtra, India
- Post Graduate Institute of Medical Education and Research
Chandigarh, Punjab, India
- Dayanand Medical College & Hospital
Ludhiana, Punjab, India
- Sri Ramachandra Medical College, Department of Psychiatry
Chennai, Tamil Nadu, India
- Ahana Hospital Llp
Madurai, Tamil Nadu, India
- Asha Hospital
Hyderabad, Telangana, India
- Behavioral Research Specialists, Llc
Glendale, California, United States
- Cbh Health, Llc
Gaithersburg, Maryland, United States
- Community Clinical Research Ccr
Austin, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 16 Jun 2020
- Primary completion
- 20 Feb 2021
- Completion
- 13 Mar 2021
- Last update posted
- 20 May 2021
- Registered enrollment
- 138
- Registry id
- NCT04461119
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.